These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 31409811)

  • 1. Benefit of Adjuvant Chemoradiotherapy in Resected Gallbladder Carcinoma.
    Kim TH; Woo SM; Lee WJ; Oh ES; Youn SH; Moon SH; Kim SS; Han SS; Park SJ; Kim DY
    Sci Rep; 2019 Aug; 9(1):11770. PubMed ID: 31409811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of adjuvant chemoradiotherapy and chemotherapy in patients with resected gallbladder carcinoma: a multi-institutional analysis (KROG 19-04).
    Lee SU; Seong J; Kim TH; Im JH; Kim WC; Kim K; Park HJ; Kim TG; Kim Y; Jeong BK; Kim JH; Kim BH; Nam TK
    Cancer Biol Med; 2021 Dec; 19(6):931-44. PubMed ID: 34919359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimating survival benefit of adjuvant therapy based on a Bayesian network prediction model in curatively resected advanced gallbladder adenocarcinoma.
    Geng ZM; Cai ZQ; Zhang Z; Tang ZH; Xue F; Chen C; Zhang D; Li Q; Zhang R; Li WZ; Wang L; Si SB
    World J Gastroenterol; 2019 Oct; 25(37):5655-5666. PubMed ID: 31602165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Chemotherapy and External-Beam Radiation Therapy on Outcomes among Patients with Resected Gallbladder Cancer: A Multi-institutional Analysis.
    Kim Y; Amini N; Wilson A; Margonis GA; Ethun CG; Poultsides G; Tran T; Idrees K; Isom CA; Fields RC; Krasnick B; Weber SM; Salem A; Martin RC; Scoggins C; Shen P; Mogal HD; Schmidt C; Beal E; Hatzaras I; Shenoy R; Cardona K; Maithel SK; Pawlik TM
    Ann Surg Oncol; 2016 Sep; 23(9):2998-3008. PubMed ID: 27169772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant Therapy Use for Patients With Inadequately Resected T1b-T3 Gallbladder Cancer.
    White MJ; Prathibha S; Gupta A; Prakash A; Ankeny JS; LaRocca CJ; Hui JYC; Tuttle TM; Brauer D; Marmor S; Jensen EH
    J Surg Res; 2024 Oct; 302():293-301. PubMed ID: 39116829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of long-term outcomes between esophagectomy and chemoradiotherapy after endoscopic resection of submucosal esophageal squamous cell carcinoma.
    Tanaka T; Ueno M; Iizuka T; Hoteya S; Haruta S; Udagawa H
    Dis Esophagus; 2019 Dec; 32(12):. PubMed ID: 30980070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Value of postoperative adjuvant chemotherapy in locally advanced rectal cancer patients with ypT1-4N0 after neo-adjuvant chemoradiotherapy].
    You KY; Peng HH; Gao YH; Chen L; Zhou GQ; Chang H; Du XJ; Xiao L; Zeng ZF; Wen BX; Liu MZ
    Zhonghua Zhong Liu Za Zhi; 2013 Sep; 35(9):708-13. PubMed ID: 24332061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nomogram for predicting the benefit of adjuvant chemoradiotherapy for resected gallbladder cancer.
    Wang SJ; Lemieux A; Kalpathy-Cramer J; Ord CB; Walker GV; Fuller CD; Kim JS; Thomas CR
    J Clin Oncol; 2011 Dec; 29(35):4627-32. PubMed ID: 22067404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant chemotherapy versus chemoradiotherapy in the management of patients with surgically resected duodenal adenocarcinoma: A propensity score-matched analysis of a nationwide clinical oncology database.
    Ecker BL; McMillan MT; Datta J; Lee MK; Karakousis GC; Vollmer CM; Drebin JA; Fraker DL; Roses RE
    Cancer; 2017 May; 123(6):967-976. PubMed ID: 28263387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of adjuvant therapy after R0 resection for patients with distal cholangiocarcinoma.
    Kim YS; Hwang IG; Park SE; Go SI; Kang JH; Park I; Oh SY; Ji JH; Song HN; Park SH; Kim ST; Park JO
    Cancer Chemother Pharmacol; 2016 May; 77(5):979-85. PubMed ID: 27017615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Adjuvant Chemotherapy in Resected T2N0 Gall Bladder Cancer.
    Kattepur AK; Patkar S; Goel M; Ramaswamy A; Ostwal V
    J Gastrointest Surg; 2019 Nov; 23(11):2232-2238. PubMed ID: 30706378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retrospective study comparing anti-EGFR monoclonal antibody plus cisplatin-based chemoradiotherapy versus chemoradiotherapy alone for stage II-IVb nasopharyngeal carcinoma and prognostic value of EGFR and VEGF expression.
    Mao L; Tan J; Wang F; Luo Y; Liu W; Zeng F; Yu B; Huang H; Lu J; Peng X; Liu X
    Clin Otolaryngol; 2019 Jul; 44(4):572-580. PubMed ID: 30972891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. D2-resected stage IIIc gastric cancer patients benefit from adjuvant chemoradiotherapy.
    Peng J; Wei Y; Zhou F; Dai J; Zhong Y; Xie C; Qin Y; Gong J; Xiong B; Zhou Y
    Cancer Med; 2016 Oct; 5(10):2773-2780. PubMed ID: 27666138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival outcomes and patterns of failure after D2 dissection and adjuvant chemoradiotherapy for locally advanced gastric cancer: a retrospective study.
    Yang W; Hu R; Li GC; Zhou ML; Wang Y; Shen LJ; Liang LP; Zhang Z
    Br J Radiol; 2018 Sep; 91(1089):20170594. PubMed ID: 29927628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the effects of adjuvant concurrent chemoradiotherapy and chemotherapy for resected biliary tract cancer.
    Kim H; Heo MH; Kim JY
    BMC Gastroenterol; 2020 Jan; 20(1):20. PubMed ID: 31992208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant Therapy in Resected Nonmetastatic Stage II-IV Gallbladder Cancer: A Generalized Propensity Score Analysis.
    Wan W; Zheng B; Sun W; Wang J; Shen S; Huang L; Liu H; Ni X; Liu H
    Oncol Res Treat; 2021; 44(7-8):390-399. PubMed ID: 34218220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of adjuvant therapy on pattern of failure and survival in curatively resected gallbladder carcinoma.
    Choudhary S; Gupta N; Verma CP; Das A; Aggarwal LM; Tewari M; Mandal A; Asthana AK
    J Cancer Res Ther; 2021; 17(4):1064-1068. PubMed ID: 34528565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant Therapy for Resected Gallbladder Cancer: Analysis of the National Cancer Data Base.
    Mantripragada KC; Hamid F; Shafqat H; Olszewski AJ
    J Natl Cancer Inst; 2017 Feb; 109(2):. PubMed ID: 27707843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemoradiotherapy Versus Chemotherapy Alone for Unresected Nonmetastatic Gallbladder Cancer: National Practice Patterns and Outcomes.
    Verma V; Surkar SM; Brooks ED; Simone CB; Lin C
    J Natl Compr Canc Netw; 2018 Jan; 16(1):59-65. PubMed ID: 29295882
    [No Abstract]   [Full Text] [Related]  

  • 20. Adjuvant chemoradiotherapy vs. radiotherapy alone in early-stage high-risk endometrial cancer: a systematic review and meta-analysis.
    Jingjing H; Rui J; Hui P
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):833-840. PubMed ID: 30720192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.